CBD as a painkiller: Efficacy not clinically proven

Cannabidiol (CBD) is marketed by some suppliers as a painkiller, e.g., for osteoarthritis of the knee. Animal experiments have shown that the substance, which is extracted from the hemp plant, has an anti-inflammatory and pain-relieving effect in arthritis. As pain researchers at MedUni Vienna were now able to show for the first time in humans, CBD is not effective as pain medication, even in high doses.

Understanding the barriers to taxing alcohol and tobacco in Nepal

Around the world, taxes on tobacco, alcohol and junk food have been used to reduce consumption of those products, according to the World Health Organization (WHO). New research led by an investigator in the Penn State College of Health and Human Development identified reasons these taxes remain low in Nepal, a lower-income nation with high rates of smoking and alcohol consumption.

A one-stop hub for SARS-CoV-2 genome data integration, variant monitoring and risk pre-warning

COVID-19 is the most extensive and consequential epidemic in nearly a century. The number of genomic sequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) far exceeds the sum of sequences of other known viruses. The vast number of genome sequences presents unprecedented challenges for rapid integration, analysis, and data mining.

LS-MFEZ posts $1.4bn growth from 2019

By NATION REPORTER

INVESTMENTS worth US$1.4 billion has been recorded at the Lusaka South Multi-Facility Economic Zone (LS-MFEZ) from 2019 to date, driven by increase in investors in the area.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.